362 related articles for article (PubMed ID: 23665205)
21. Trafficking of QD-conjugated MPO-ANCA in murine systemic vasculitis and glomerulonephritis model mice.
Hoshino A; Nagao T; Ito-Ihara T; Ishida-Okawara A; Uno K; Muso E; Nagi-Miura N; Ohno N; Tokunaka K; Naoe S; Hashimoto H; Yasuhara M; Yamamoto K; Suzuki K
Microbiol Immunol; 2007; 51(5):551-66. PubMed ID: 17579266
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
Jennette JC; Xiao H; Falk RJ
J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
[TBL] [Abstract][Full Text] [Related]
23. A novel mouse model for MPO-ANCA-associated glomerulonephritis.
Yumura W; Itabashi M; Ishida-Okawara A; Tomizawa K; Yamashita J; Kaneshiro Y; Nihei H; Suzuki K
Microbiol Immunol; 2006; 50(2):149-57. PubMed ID: 16490933
[TBL] [Abstract][Full Text] [Related]
24. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Sanders JS; van Goor H; Hanemaaijer R; Kallenberg CG; Stegeman CA
Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
[TBL] [Abstract][Full Text] [Related]
25. IFN-γ-producing effector CD8 T lymphocytes cause immune glomerular injury by recognizing antigen presented as immune complex on target tissue.
Tsumiyama K; Hashiramoto A; Takimoto M; Tsuji-Kawahara S; Miyazawa M; Shiozawa S
J Immunol; 2013 Jul; 191(1):91-6. PubMed ID: 23720810
[TBL] [Abstract][Full Text] [Related]
26. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies.
Xiao H; Heeringa P; Liu Z; Huugen D; Hu P; Maeda N; Falk RJ; Jennette JC
Am J Pathol; 2005 Jul; 167(1):39-45. PubMed ID: 15972950
[TBL] [Abstract][Full Text] [Related]
27. Interstitial Foxp3-positive T cells may predict renal survival in patients with myeroperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Yoshimura J; Fukami K; Koike K; Nagano M; Matsumoto T; Iwatani R; Kusumoto T; Hazama T; Ueda S; Adachi H; Hirai Y; Takasu K; Ohshima K; Yamagishi S; Okuda S
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):879-83. PubMed ID: 20528980
[TBL] [Abstract][Full Text] [Related]
28. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
[TBL] [Abstract][Full Text] [Related]
29. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
[TBL] [Abstract][Full Text] [Related]
30. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
[TBL] [Abstract][Full Text] [Related]
31. Spatiotemporal expression of chemokines and chemokine receptors in experimental anti-myeloperoxidase antibody-mediated glomerulonephritis.
van der Veen BS; Petersen AH; Belperio JA; Satchell SC; Mathieson PW; Molema G; Heeringa P
Clin Exp Immunol; 2009 Oct; 158(1):143-53. PubMed ID: 19737241
[TBL] [Abstract][Full Text] [Related]
32. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
33. The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis.
Dick J; Gan PY; Kitching AR; Holdsworth SR
PLoS One; 2018; 13(1):e0190655. PubMed ID: 29315316
[TBL] [Abstract][Full Text] [Related]
34. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
35. The role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritis.
Arimura Y; Kawashima S; Yoshihara K; Komagata Y; Kaname S; Yamada A
Clin Exp Nephrol; 2013 Oct; 17(5):634-637. PubMed ID: 23504409
[TBL] [Abstract][Full Text] [Related]
36. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
37. A case of CREST syndrome and myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
Yamashita K; Yorioka N; Kyuden Y; Naito T; Tanji C; Ueda C; Usui K; Shigemoto K; Harada S; Yamakido M
Clin Nephrol; 2000 Apr; 53(4):296-300. PubMed ID: 10809419
[TBL] [Abstract][Full Text] [Related]
38. [A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents].
Fujimoto T; Kimura A; Ameno M; Shiiki H; Dohi K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):172-7. PubMed ID: 9134836
[TBL] [Abstract][Full Text] [Related]
39. Thymic deletion and regulatory T cells prevent antimyeloperoxidase GN.
Tan DS; Gan PY; O'Sullivan KM; Hammett MV; Summers SA; Ooi JD; Lundgren BA; Boyd RL; Scott HS; Kitching AR; Chidgey AP; Holdsworth SR
J Am Soc Nephrol; 2013 Mar; 24(4):573-85. PubMed ID: 23393320
[TBL] [Abstract][Full Text] [Related]
40. Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizoribine.
Nagao T; Kusunoki R; Iwamura C; Kobayashi S; Yumura W; Kameoka Y; Nakayama T; Suzuki K
Microbiol Immunol; 2013 Sep; 57(9):640-50. PubMed ID: 23829825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
